Australia's Cochlear names Holliday-Smith New Board Chairman
This article was originally published in PharmAsia News
Executive SummaryCochlear of Australia appointed a new chairman, elevating a board member, Rick Holliday-Smith
You may also be interested in...
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.